Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dopamine–prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity
Claudia Gragnoli, Gloria Reeves, J Reazer, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 4, pp. e785-e785
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Co‐shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome
Teodor T. Postolache, Laura del Bosque‐Plata, Serge Jabbour, et al.
American Journal of Medical Genetics Part B Neuropsychiatric Genetics (2019) Vol. 180, Iss. 3, pp. 186-203
Open Access | Times Cited: 99
Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
Yutaka Mizuki, Shinji Sakamoto, Yuko Okahisa, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 5, pp. 367-382
Open Access | Times Cited: 62
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu‐Hua Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7092-7092
Open Access | Times Cited: 24
Recent findings on subjective well‐being and physical, psychiatric, and social comorbidities in individuals with schizophrenia: A literature review
Yupeng He, Ayako Tanaka, Taro Kishi, et al.
Neuropsychopharmacology Reports (2022) Vol. 42, Iss. 4, pp. 430-436
Open Access | Times Cited: 22
Prolactin (PRL): Physiology and Physiopathology in Depression Subtypes and Metabolic Disorders and Their Comorbidity
Michele Perrelli, Claudia Gragnoli
(2025), pp. 1-21
Closed Access
Associations among the TREM-1 Pathway, Tau Hyperphosphorylation, Prolactin Expression, and Metformin in Diabetes Mice
Hai Duc Nguyen, Ngoc Minh Hong Hoang, Won Hee Jo, et al.
NeuroImmunoModulation (2022) Vol. 29, Iss. 4, pp. 359-368
Closed Access | Times Cited: 16
Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis
Maria Giuseppina Petruzzelli, Mariella Margari, Antonia Peschechera, et al.
BMC Psychiatry (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 22
Prolactin selectively transported to cerebrospinal fluid from blood under hypoxic/ischemic conditions
Naoto Tani, Tomoya Ikeda, Miho Watanabe, et al.
PLoS ONE (2018) Vol. 13, Iss. 6, pp. e0198673-e0198673
Open Access | Times Cited: 21
Levels of Trace Elements in Erythrocytes as Endocrine Disruptors in Obese and Nonobese Women with Polycystic Ovary Syndrome
Kamila Pokorska‐Niewiada, Agnieszka Brodowska, Jacek Brodowski, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 2, pp. 976-976
Open Access | Times Cited: 11
Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment
Tommaso B. Jannini, Andrea Sansone, Rodolfo Rossi, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 9, pp. 1065-1080
Closed Access | Times Cited: 9
The Obesity–Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients
Adonis Sfera, Carolina Osorio, Luzmin Inderias, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 16
The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment
Tzu‐Hua Wu, Chieh‐Hsin Lin, Kah Kheng Goh, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 12
Metabolic pathways in the periphery and brain: Contribution to mental disorders?
Andrzej Nagalski, Kamil Koziński, M. Wisniewska
The International Journal of Biochemistry & Cell Biology (2016) Vol. 80, pp. 19-30
Closed Access | Times Cited: 12
COMT Variants are Associated With Breast and Nipple Pain
Tumilara Aderibigbe, Shannon L. Kelleher, Wendy A. Henderson, et al.
Journal of Pain (2024) Vol. 25, Iss. 9, pp. 104568-104568
Closed Access | Times Cited: 1
Striatal dopamine gene network moderates the effect of early adversity on the risk for adult psychiatric and cardiometabolic comorbidity
Bárbara Barth, Danusa Mar Arcego, Euclides José de Mendonça Filho, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Estrogen receptor: A potential linker of estrogenic and dopaminergic pathways in zebrafish larvae following deltamethrin exposure
Tiantian Hu, Yongfang Ma, Kun Qiao, et al.
The Science of The Total Environment (2021) Vol. 802, pp. 149938-149938
Closed Access | Times Cited: 10
The prevalence, risk factors and clinical correlates of diabetes mellitus in Chinese patients with schizophrenia
Lijuan Huo, Guangya Zhang, Xiangdong Du, et al.
Schizophrenia Research (2020) Vol. 218, pp. 262-266
Closed Access | Times Cited: 10
Decipher the inhibitory potential of phytocompounds from Leptadenia reticulata on dopamine D2 receptor to enhance prolactin secretion
Roshan Kumar Sharma, Sunil Jalalpure, Mahendra Kumar Chouhan, et al.
Drug Research (2022) Vol. 72, Iss. 04, pp. 189-196
Closed Access | Times Cited: 6
A systems biology approach for discovering the cellular and molecular aspects of psychogenic non-epileptic seizure
Mahdi Malekpour, Aida Jafari, Mohammad Kashkooli, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 3
Dopamine D4 receptor protected against hyperglycemia-induced endothelial dysfunction via PI3K /eNOS pathway
He Wang, Yong‐Gang Yao, Juncheng Liu, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 518, Iss. 3, pp. 554-559
Closed Access | Times Cited: 9
Prolactin, metabolic and immune parameters in naïve subjects with a first episode of psychosis
Clemente García-Rizo, Javier Vázquez‐Bourgon, Javier Labad, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 110, pp. 110332-110332
Closed Access | Times Cited: 8
Dopaminergic system and its relationship with the hypothalamic-pituitary-gonadal and hypothalamic-pituitary-thyroid systems (review)
Н Лаверова, Уро Ран, I. N. Molodovskaya, et al.
Сибирский научный медицинский журнал (2020), Iss. 6
Open Access | Times Cited: 5
A study on the improvement of lipid metabolism disorders in the treatment of hyperprolactinemia rats with liver-depression by Sini San based on AKT1/TNF/IL6 signaling pathway
Weidong Xu, Shasha Tian, Guanqun Mao, et al.
Current Research in Food Science (2024) Vol. 9, pp. 100853-100853
Open Access
Molecular docking analysis of Polyscias scutellaria active compounds as inhibitor of dopamine D2 receptors to increase prolactin secretion
Budiono Budiono, Sumirah Budi Pertami, Siti Nur Arifah, et al.
AIP conference proceedings (2021) Vol. 2353, pp. 030034-030034
Open Access | Times Cited: 3
Distinctive features of the hypothalamic-pituitary-gonadal axis and the level of dopamine in men of the European and Asian North
Е. В. Типисова, I. N. Molodovskaya, V.А. Alikina, et al.
Russian Clinical Laboratory Diagnostics (2022) Vol. 67, Iss. 5, pp. 261-266
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top